The 5th (2022) China Medical Device Innovation and Entrepreneurship Competition artificial intelligence and medical robot category competition ended on August 27 at the Pharmaceutical Industry Incubation Park of Tianmu Pharmaceutical Port in Lin'an District, Hangzhou.

40 outstanding project teams from all over the country conducted an "AI showdown" in the medical device industry in Lin'an, presenting a colorful and fierce competition to the judges and experts and various investment and financing institutions and enterprise representatives on the spot.

This time The competition focuses on high-quality artificial intelligence and medical robot projects, covering the application direction and innovative technologies of emerging medical devices. The judges of the competition are served by well-known experts in various fields such as clinical, technical, testing, and investment in the industry, and comprehensively score the clinical value, social value, innovation and technology of the project. Some experts said that the industry generally agrees that medical robots are the future development direction of the medical industry, so whether it is primary or secondary, the capital market does not hesitate to pay attention to and enthusiasm.

Among them, to Guangdong Bogong Sanluwu Robot Technology Co., Ltd. (robot 365) was shortlisted for the "Life Sciences Laboratory Automation Program" project for the representative.

Robot 365 Company focuses on the research and development, design, production and sales of AI intelligent robot medical equipment and smart medical scene application solutions, creating the first brand of intelligent robot medical equipment, and is committed to the development of easy-to-operate, flexible and safe medical robot equipment to Help users improve work efficiency. Adhering to the concept of "achieving customers and working hard", the company has a large number of successful application cases of intelligent laboratory equipment in the domestic medical stem cell industry, and is the pioneer of stem cell cultivation robots.

In 2021, Robot 365's first stem cell cultivation robot was born and successfully delivered, effectively improving the domestic pain points in the laboratory automation industry, realizing laboratory automation in the field of life sciences, and greatly improving the laboratory's research and production efficiency. In 2022, the robotics 365 life science laboratory automation solution has been implemented in many leading cell companies in China, and has achieved tens of thousands of experimental zero-error results in complex scenarios, effectively solving the problem of low efficiency and errors in biological laboratories. High, uneven product quality and other issues.

At present, Robot 365 has the core advantages of laboratory automation in the domestic life science field, has rich experience in project cooperation, and can provide users with customized laboratory automation solutions.